<p>BioCryst Pharmaceuticals Inc. announced that Nancy J. Hutson, Ph.D. will retire from the Board of Directors, effective either upon the closing of the proposed acquisition of Astria Therapeutics, Inc. or at the company’s 2026 annual meeting of stockholders, whichever comes first. Vincent J. Milano has been elected as the next Chair of the Board, to assume the role upon Dr. Hutson’s retirement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-007878), on December 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

BCRX

<p>BioCryst Pharmaceuticals Inc. announced that Vincent J. Milano will become the next Chair of the Board, succeeding Nancy J. Hutson, Ph.D., who will retire upon the closing of the proposed acquisition of Astria Therapeutics, Inc. or at the 2026 annual meeting of stockholders. This leadership change was disclosed via the U.S. SEC's EDGAR system.</p>

Vincent J. Milano Named Next Chair of BioCryst Pharmaceuticals Board